market

Rivals Emerge to Ozempic and Zepbound—but With a Lag



Big pharma challengers like Roche and Amgen could grab a slice of the obesity market.



READ SOURCE

Read More   The investing world reacts to death of Berkshire legend Charlie Munger

This website uses cookies. By continuing to use this site, you accept our use of cookies.